Continuity Biosciences and Breakthrough T1D Team Up for Innovative Cell Therapy Advances Continuity Biosciences and Breakthrough T1D join forces to advance the development of the NICHE® platform, aimed at treating type 1 diabetes through innovative cell therapy.

Continuity Biosciences and Breakthrough T1D Team Up for Innovative Cell Therapy Advances #USA #CARY #Type1Diabetes #CellTherapy #NICHEPlatform